Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Ethanolamine | HCID 700 | — |
| Reactant | 1,1-Dichloroethane | HCID 6365 | — |
| Reactant | Sodium Carbonate | HCID 10340 | — |
| Reactant | HCID 20508545 | HCID 20508545 | — |
| Reactant | 8-amino-6-(o-fluorophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine | HCID 20508552 | — |
| Reactant | HCID 20508556 | HCID 20508556 | — |
| Solvent | Acetonitrile | HCID 6342 | — |
| Product | HCID 20508555 | HCID 20508555 | — |
Reaction Steps
A dichloroethane solution of [6-(o-fluorophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]benzodiazepin-8-yl]-isocyanate, prepared as described in paragraph (a) of Example 1 from 5 g (16.3 mmol) of 8-amino-6-(o-fluorophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine, is added dropwise at room temperature while stirring to a suspension of 6.2 g (58.5 mmol) of sodium carbonate in 3 ml (49.8 mmol) of ethanolamine and 40 ml of acetonitrile. After 20 hours, the mixture is partitioned between 500 ml of water and 500 ml of methylene chloride/ethanol (4:1) at 50° C. The separated aqueous phase is treated again in an analogous manner, the combined organic extracts are dried and concentrated in vacuo. Crystallisation of the residue from ethanol yields 1-[6-(o-fluorophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]-benzodiazepin-8-yl]-3-(2-hydroxyethyl)urea of melting point 228°-230° C.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04374773 |
|---|
| Source dataset | uspto-grants-1983_02 |
|---|
| ORD ID | ord-f7aba7b1c0f8454db2c45f1650b68ebb |
|---|
| Source note | uspto-grants-1983_02 |
|---|